| 1 |
34169794 | Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease. | 2021 Aug |
1 |
| 2 |
34464022 | Genitourinary Syndrome of Menopause. | 2021 Nov |
1 |
| 3 |
25936229 | Selective estrogen receptor modulators in clinical practice: a safety overview. | 2015 Jun |
1 |
| 4 |
26634778 | Ospemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use. | 2015 |
1 |
| 5 |
24918836 | Ospemifene for the treatment of dyspareunia in postmenopausal women. | 2014 May |
1 |
| 6 |
23985562 | Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. | 2013 Sep |
1 |
| 7 |
24055829 | Tissue selectivity of ospemifene: pharmacologic profile and clinical implications. | 2013 Dec 11 |
1 |
| 8 |
18455292 | Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells. | 2008 Jul 16 |
2 |